Innovations Stem Cell Center Earns Top U.S. Recognition for Second Consecutive Year and Returns as October Cover Story

Dallas physician Dr. Bill Johnson puts patient outcomes at the center of a larger conversation about stem cell therapy and chronic disease

DALLAS, Oct. 16, 2026 /PRNewswire/ -- Innovations Stem Cell Center has earned national recognition from Life Sciences Review for the second consecutive year, receiving the publication's "Top Stem Cell Therapy Treatments Company 2026" designation and returning as the cover story of its October issue.

The recognition highlights a Dallas practice pursuing a practical question with national relevance: How can patients and physicians better understand what happens after stem cell treatment?

Led by Bill Johnson, MD, MMM, Innovations Stem Cell Center combines a consistent protocol using cells derived from a patient's own fat tissue with an expanding clinical outcomes registry. The initiative is designed to track changes in symptoms, daily function and objective clinical measurements over time—with particular attention to chronic medical conditions beyond orthopedic care.

"Patients want to know whether they can breathe more comfortably, walk farther or get through the day with less fatigue," said Johnson. "Our goal is to document those changes carefully, understand who improves and be equally clear about who does not."

Moving the conversation beyond joint pain

The October profile explores Johnson's approach to regenerative medicine, shaped by more than four decades of experience in internal medicine. His practice's outcomes initiative includes chronic lung disease, autoimmune disorders, kidney disease and neurological conditions—areas central to his interest in understanding the potential role and limitations of regenerative care.

The registry is being developed to incorporate a review of approximately 1,200 historical patient records alongside prospective follow-up using defined measures. It will distinguish patient-reported improvement from objective findings and separate historical observations from data collected going forward.

"For us, this second recognition is an opportunity to bring more attention to the questions that matter," Johnson said. "What are we measuring? How long are we following patients? And how clearly are we explaining both the possibilities and the uncertainties?"

A physician available to explain the story behind the headlines

Johnson welcomes interview requests from television, radio, podcasts and print or digital newsrooms exploring regenerative medicine and chronic disease. Topics include:

• What patients should ask before considering stem cell therapy: cell source, treatment approach, supporting evidence, risks and realistic expectations.
• Why follow-up matters: how symptom reports and clinical measurements can tell different parts of a patient's story.
• Stem cell therapy beyond orthopedics: why Innovations is tracking outcomes in lung, autoimmune, kidney and neurological conditions.

The October feature, "Standardizing Stem Cell Care for an Evidence-Driven Future," is available at Life Sciences Review.

About Innovations Stem Cell Center

Innovations Stem Cell Center is a Dallas–Fort Worth regenerative medicine practice led by Bill Johnson, MD, MMM. The practice focuses on autologous adipose-derived cell procedures, using cells obtained from a patient's own fat tissue, and emphasizes patient education, consistent clinical protocols and longitudinal outcomes tracking. Learn more at innovationsstemcellcenter.com.

Media Contact
Bill Johnson, MD, MMM
|Innovations Stem Cell Center
214-420-7970
[email protected]

SOURCE iMedstem LLC DBA Innovations Stem Cell Center